Re-irradiation With Carbon Ion Radiotherapy for Pelvic Rectal Cancer Recurrences in Patients Previously Irradiated to the Pelvis

Background/Aim: Re-irradiation of locally recurrent rectal cancer poses challenges due to the proximity of critical organs, such as the bowel. This study aimed at evaluating the safety and efficacy of re-irradiation with Carbon Ion Radiotherapy (CIRT) in rectal cancer patients with local recurrence. Patients and Methods: Between 2014 and 2018, 14 patients were treated at the National Center of Oncological Hadrontherapy (CNAO Foundation) with CIRT for locally recurrent rectal cancer. Results: All patients concluded the treatment. No G≥3 acute/late reaction nor pelvic infections were observed. The 1-year and 2-year local control rates were, 78% and 52%, respectively, and relapse occurred close to the bowel in 6 patients. The 1-year and 2-year overall survival rates were 100% and 76.2% each; while the 1-year and 2-year metastasis free survival rates were 64.3% and 43%. Conclusion: CIRT as re-irradiation for locally recurrent rectal cancer emerges as a safe and valid treatment with an acceptable rate of morbidity of surrounding healthy tissue.

[1]  F. Valvo,et al.  The Role of Particle Therapy in the Risk of Radio-induced Second Tumors: A Review of the Literature , 2019, AntiCancer Research.

[2]  F. Valvo,et al.  Letter to the Editor concerning “Re-irradiation in gynaecological cancers, present experiences and future hopes” , 2019, Journal of Radiation Oncology.

[3]  F. Valvo,et al.  Feasibility of Carbon Ion Radiotherapy in the Treatment of Gynecological Melanoma , 2019, In Vivo.

[4]  F. Bray,et al.  Global trends in colorectal cancer mortality: projections to the year 2035 , 2019, International journal of cancer.

[5]  L. Beck,et al.  Oncology communities of practice: insights from a qualitative analysis. , 2018, Current oncology.

[6]  L. Karimi,et al.  Brilliant health service management: challenging perceptions and changing HR practices in health services , 2018, Asia Pacific Journal of Human Resources.

[7]  M. Ciocca,et al.  Characterization of a multilayer ionization chamber prototype for fast verification of relative depth ionization curves and spread-out-Bragg-peaks in light ion beam therapy. , 2018, Medical physics.

[8]  Mitsugu Sekimoto,et al.  Carbon-Ion Radiation Therapy for Pelvic Recurrence of Rectal Cancer. , 2016, International journal of radiation oncology, biology, physics.

[9]  F. Valvo,et al.  Surgical spacer placement prior carbon ion radiotherapy (CIRT): an effective feasible strategy to improve the treatment for sacral chordoma , 2016, World Journal of Surgical Oncology.

[10]  R. Orecchia,et al.  Dose prescription in carbon ion radiotherapy: How to compare two different RBE-weighted dose calculation systems. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  Gina Brown,et al.  Systematic review of prognostic importance of extramural venous invasion in rectal cancer. , 2016, World journal of gastroenterology.

[12]  Marco Marabelli,et al.  Dominant Cognitive Frames and the Innovative Power of Social Networks , 2016 .

[13]  Sandro Rossi,et al.  The National Centre for Oncological Hadrontherapy (CNAO): Status and perspectives. , 2015, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[14]  W. Gu,et al.  CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer , 2015, Radiation oncology.

[15]  S Giordanengo,et al.  The CNAO dose delivery system for modulated scanning ion beam radiotherapy. , 2014, Medical physics.

[16]  G Baroni,et al.  Commissioning and Quality Assurance of an Integrated System for Patient Positioning and Setup Verification in Particle Therapy , 2014, Technology in cancer research & treatment.

[17]  K Parodi,et al.  Dosimetric accuracy assessment of a treatment plan verification system for scanned proton beam radiotherapy: one-year experimental results and Monte Carlo analysis of the involved uncertainties , 2013, Physics in medicine and biology.

[18]  Alberto Córdoba,et al.  A medical knowledge management system based on expert tagging (MKMST) , 2013, DATA 2013.

[19]  Roberto Orecchia,et al.  Dose prescription in carbon ion radiotherapy: a planning study to compare NIRS and LEM approaches with a clinically-oriented strategy , 2012, Physics in medicine and biology.

[20]  R. Pötter,et al.  Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: the PANDORA-01 trial , 2012, BMC Cancer.

[21]  L. Li,et al.  Accelerated hyperfractionation field-involved re-irradiation combined with concurrent capecitabine chemotherapy for locally recurrent and irresectable rectal cancer. , 2012, The British journal of radiology.

[22]  L. Påhlman,et al.  Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  C. Alvarado,et al.  Knowledge systems, health care teams, and clinical practice: a study of successful change , 2010, Advances in health sciences education : theory and practice.

[24]  J. Monson,et al.  Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial , 2009, The Lancet.

[25]  P. Bhosale,et al.  Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer. , 2008, International journal of radiation oncology, biology, physics.

[26]  F. Valvo,et al.  Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. , 2003, International journal of radiation oncology, biology, physics.

[27]  M Scholz,et al.  Treatment planning for heavy-ion radiotherapy: calculation and optimization of biologically effective dose. , 2000, Physics in medicine and biology.

[28]  J. Hendry,et al.  Radiobiology for the Radiologist , 1979, British Journal of Cancer.

[29]  J. Skibber,et al.  Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicity. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  H. Tsuji,et al.  [Carbon ion radiotherapy]. , 2016, Nihon rinsho. Japanese journal of clinical medicine.

[31]  M. Büchler,et al.  Reirradiation Using Carbon Ions in Patients with Locally Recurrent Rectal Cancer at HIT: First Results , 2014, Annals of Surgical Oncology.

[32]  Marco Durante,et al.  Charged particles in radiation oncology , 2010, Nature Reviews Clinical Oncology.

[33]  S. Straus,et al.  Knowledge translation in health care : moving from evidence to practice , 2009 .

[34]  Leslie H. Sobin,et al.  TNM Classification of Malignant Tumours, 7th Edition , 2009 .